These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29122048)

  • 1. EVALUATION OF PATIENT AND PUBLIC INVOLVEMENT INITIATIVES IN HEALTH TECHNOLOGY ASSESSMENT: A SURVEY OF INTERNATIONAL AGENCIES.
    Weeks L; Polisena J; Scott AM; Holtorf AP; Staniszewska S; Facey K
    Int J Technol Assess Health Care; 2017 Jan; 33(6):715-723. PubMed ID: 29122048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FOR ACTION.
    Abelson J; Wagner F; DeJean D; Boesveld S; Gauvin FP; Bean S; Axler R; Petersen S; Baidoobonso S; Pron G; Giacomini M; Lavis J
    Int J Technol Assess Health Care; 2016 Jan; 32(4):256-264. PubMed ID: 27670693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey on the involvement of consumers in health technology assessment programs.
    Hailey D; Nordwall M
    Int J Technol Assess Health Care; 2006; 22(4):497-9. PubMed ID: 16984683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of consumers in health technology assessment activities by Inahta agencies.
    Hailey D; Werkö S; Bakri R; Cameron A; Göhlen B; Myles S; Pwu J; Yothasamut J
    Int J Technol Assess Health Care; 2013 Jan; 29(1):79-83. PubMed ID: 23217279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the role of the public in Health Technology Assessment (HTA) and HTA-informed decision-making processes.
    Street J; Stafinski T; Lopes E; Menon D
    Int J Technol Assess Health Care; 2020 Apr; 36(2):87-95. PubMed ID: 32151290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strengthening international patient advocacy perspectives on patient involvement in HTA within the HTAi Patient and Citizen Involvement Interest Group - Commentary.
    Wale JL; Scott AM; Bertelsen N; Meade N;
    Res Involv Engagem; 2017; 3():3. PubMed ID: 29062528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Citizen participation in the context of health technology assessment].
    Freile-Gutiérrez B
    Rev Med Chil; 2014 Jan; 142 Suppl 1():S27-32. PubMed ID: 24861177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An international survey of the public engagement practices of health technology assessment organizations.
    Whitty JA
    Value Health; 2013; 16(1):155-63. PubMed ID: 23337227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients, users, caregivers, and citizens' involvement in local health technology assessment unit in Quebec: a survey.
    Poder TG; Safianyk C; Fournier MF; Ganache I; Touré M; Pomey MP; Gagnon MP
    Int J Technol Assess Health Care; 2020 Sep; 37():e5. PubMed ID: 32988424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and facilitators influencing ethical evaluation in health technology assessment.
    Assasi N; Schwartz L; Tarride JE; O'Reilly D; Goeree R
    Int J Technol Assess Health Care; 2015 Jan; 31(3):113-23. PubMed ID: 26179275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 'Top 10' Challenges for Health Technology Assessment: INAHTA Viewpoint.
    O'Rourke B; Werkö SS; Merlin T; Huang LY; Schuller T
    Int J Technol Assess Health Care; 2020; 36(1):1-4. PubMed ID: 31775943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTA Training for Healthcare Professionals: International Overview of Initiatives Provided by HTA Agencies and Organizations.
    Hoxhaj I; Castagna C; Calabrò GE; Boccia S
    Front Public Health; 2022; 10():795763. PubMed ID: 35223734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moving cautiously: Public involvement and the health technology assessment community.
    Gauvin FP; Abelson J; Giacomini M; Eyles J; Lavis JN
    Int J Technol Assess Health Care; 2011 Jan; 27(1):43-9. PubMed ID: 21262071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Public Health Interventions: A Neglected Area in Health Technology Assessment.
    Stojanovic J; Wübbeler M; Geis S; Reviriego E; Gutiérrez-Ibarluzea I; Lenoir-Wijnkoop I
    Front Public Health; 2020; 8():106. PubMed ID: 32391300
    [No Abstract]   [Full Text] [Related]  

  • 15. Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level.
    Calabrò GE; La Torre G; de Waure C; Villari P; Federici A; Ricciardi W; Specchia ML
    BMC Health Serv Res; 2018 Mar; 18(1):148. PubMed ID: 29490647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAKEHOLDER INVOLVEMENT IN THE HEALTH TECHNOLOGY ASSESSMENT PROCESS IN LATIN AMERICA.
    Pichon-Riviere A; Soto N; Augustovski F; Sampietro-Colom L
    Int J Technol Assess Health Care; 2018 Jan; 34(3):248-253. PubMed ID: 29888698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community views and perspectives on public engagement in health technology assessment decision making.
    Wortley S; Tong A; Howard K
    Aust Health Rev; 2017 Mar; 41(1):68-74. PubMed ID: 27050156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAKEHOLDER INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT AT NATIONAL LEVEL: A STUDY FROM IRAN.
    Yazdizadeh B; Shahmoradi S; Majdzadeh R; Doaee S; Bazyar M; Souresrafil A; Olyaeemanesh A
    Int J Technol Assess Health Care; 2016 Jan; 32(3):181-9. PubMed ID: 27524462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient advocate perspectives on involvement in HTA: an international snapshot.
    Scott AM; Wale JL;
    Res Involv Engagem; 2017; 3():2. PubMed ID: 29062527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the International Network of Agencies for Health Technology Assessment.
    Hailey D
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():24-7. PubMed ID: 19500434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.